|
|
 |
|
|
My product in 2008 - PA or PR?
|
14-Jun-2008
|
 As Plato said: “The price good men pay for indifference to public affairs is to be ruled by evil men.” Why, asks Nick May, is public affairs so often the long, lost second cousin in the marketing mix?
Read more...
|
|
Are you media-savvy enough?
|
13-Jun-2008
|
 The two words 'media relations' have caused much discussion within pharmaceutical companies over the years. Cherry Wood defends the industry's right to be innovative - albeit code-abiding - in the way it creates awareness
Read more...
|
|
Taking a leaf from their book
|
12-Jun-2008
|
 Can it be right, ask Neil and Tom Kendle, that online bookseller Amazon knows more about the interests of each of its 100 million customers than the average drug company knows about most of its key opinion leaders?
Read more...
|
|
Can UK pharma become a world player?
|
11-Jun-2008
|
 A recent report from PricewaterhouseCoopers predicts that the global pharma market will more than double in value by 2020. John Clare asks if UK pharma is heading for relegation or can it fight off fierce competition to make the premier division?
Read more...
|
|
A refining process
|
14-May-2008
|
 Key account management is not a revolution but a distillation of the marketing mix that can help sales forces deal with NHS changes
Read more...
|
|
Whatever next?
|
13-May-2008
|
 The PPRS changes could spell the end of pharma as we know it unless a compromise is reached
Read more...
|
|
Creating a classic
|
10-Apr-2008
|
 Pharma could benefit from emulating the style and thinking behind successful consumer ads to make an impact
Read more...
|
|
Growth Spurt
|
10-Apr-2008
|
 Pharma must change its supply chain model to maximise on future growth opportunities resulting from a global surge in product demand
Read more...
|
|
|
|
|
|
Better tolerated treatments are needed in overactive bladder and urinary incontinence
It has been a testing five years
Following a launch reception on 13
Pharma must adapt as the move towards personalised medicine gathers pace
As Brian Gunson and Sarah Hart explain, Web 2.0 allows marketers to have the relationship they’ve always said they wanted… open and transparent, with two-way conversations
It’s a hotly debated subject and individual cases make headline news. Isn’t it time, asks Liz Shanahan, for pharma to accept that patient top-ups may be inevitable?
Employers must adapt their management styles and culture to get the best performance from their staff
The emergence of medtech brings a seed of hope to healthcare
Understanding an audience's psychology and behaviour creates campaigns that deliver good RoI
Therapeutics that turn off mutant genes could light the way in fighting diseases
To meet market access challenges, pharma must adopt an integrated, streamlined approach
Will the government stick with unpopular primary care changes in the run up to an election?
Shouldn't the NHS have the discretion to buy what it wants?
Social media is no passing craze and pharma needs to join in
A compelling reason to participate is key for medical education programmes
Marketers need to personalise the message to maximise online opportunities
Pharma companies must learn to extract more value from existing products
Is the EU brave enough to make radical policy change to tackle parallel trade?
Global strategies can be adapted to suit the local customer
NHS Trust patients are being dumped into observation-lots to meet A&E waiting time targets
Why is pharma still tentative in its use of e-marketing channels?
The NHS' new patient-driven choice agenda requires detailed, highly targeted information analysis
BHBIA celebrates the very best of business intelligence
As the monopoly held by GPs ends, new primary care routes are opening to patients
The public may find it hard to reconcile approval with seeming ineffectiveness
